Skip to main content

Languages

Speakers


Please note: More info to come. This page will be updated on an ongoing basis.

Dr Alan Bernstein, OC, PhD, FRSC
President and Chief Executive Officer, Canadian Institute for Advanced Research

Dr Alan Bernstein is the President and CEO of CIFAR (the Canadian Institute for Advanced Research), whose mission is to connect the world’s best minds through global research networks that address important and complex challenges facing humanity.

An internationally known biomedical scientist, Dr Bernstein was the executive director of the Global HIV Vaccine Enterprise, an international alliance of researchers and funders charged with accelerating the search for an HIV vaccine, from 2008-2011. Previously, he served as the founding president of the Canadian Institutes of Health Research (2000-2007), Canada’s federal agency for the support of health research. In that capacity, he led the transformation of health research in Canada.

After receiving his PhD from the University of Toronto, and following postdoctoral work in London, Dr Bernstein joined the Ontario Cancer Institute (1974-1985). In 1985, he was appointed to the new Samuel Lunenfeld Research Institute in Toronto, was named Associate Director in 1988 and then Director of Research (1994-2000). Author of over 225 scientific publications, Dr Bernstein has made extensive contributions to the study of stem cells, hematopoiesis and cancer. He chairs or is a member of advisory and review boards in Canada, the US, UK, Italy and Australia. Dr Bernstein has received numerous awards and honourary degrees for his contributions to science, including the 2008 Gairdner Wightman Award. He is a Senior Fellow of both Massey College and the Munk School of Global Affairs, and is an Officer of the Order of Canada.



Lisa A Bero, PhD
Professor, University of California, San Francisco
Director, San Francisco Branch US Cochrane Center

Lisa A Bero is a pharmacologist who studies how science is translated into clinical practice and health policy. She has developed and validated methods for assessing bias in the design, conduct and dissemination of research on pharmaceuticals, tobacco and chemicals. Dr Bero has also conducted analyses to examine the dissemination and policy implications of research evidence. Her international activities include advisor to the World Health Organization Department of Essential Medicines and Pharmaceutical Policies, member of the WHO Essential Medicines Committee and member of the Pan American Health Organization Advisory Committee on Health Research. She is Director of the San Francisco Branch of the United States Cochrane Center and the World Health Organization Collaborating Centre on Pharmaceutical Research and Science Policy. She was an elected member of The Cochrane Collaboration Steering Group for 12 years and serves on several national and international committees related to conflicts of interest and research, such as the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice.



David Bornstein
Author, How to Change the World: Social Entrepreneurs and the Power of New Ideas (Oxford University Press)
Journalist,The New York Times

David Bornstein is a journalist and author who focuses on social innovation. He co-authors the Fixes column in The New York Times Opinionator section, which explores and analyzes potential solutions to major social problems. He is the co-founder of the Solutions Journalism Network, which supports journalists who report on constructive responses to social problems, and the founder of Dowser, a media site for young journalists who cover social innovation. His books include How to Change the World: Social Entrepreneurs and the Power of New Ideas, The Price of a Dream: The Story of the Grameen Bank, and Social Entrepreneurship: What Everyone Needs to Know. He is currently completing a book on social innovation in the U.S. and Canada. He lives in New York.



Dr Tim Evans, DPhil, MD
Director, Health Nutrition and Population, World Bank

Timothy G Evans is the Director, Health, Nutrition and Population at the World Bank. Dr Evans has been active in the international health arena for more than 20 years.

 Before joining the World Bank, he was the Dean of the James P Grant School of Public Health of BRAC University in Bangladesh. Previously, he served as Assistant Director General at the World Health Organization, heading the Evidence, Information, Research and Policy Clusters, where he oversaw the production of the annual World Health Report.

Dr Evans has been a leader in advancing global health equity and health systems performance throughout his career, notably through his work with the Rockefeller Foundation and the Harvard School of Public Health and with his contributions to the development of innovative partnerships, including the Global Alliance on Vaccines and Immunization, INDEPTH and Health Metrics networks, the Global Health Workforce Alliance and the World Alliance for Patient Safety.

Dr Evans earned his DPhil in agricultural economics at Oxford, and pursued medical and postgraduate studies at McMaster and Harvard Universities.



Dr Luiz Augusto Cassanha Galvão
Assistant Director, Pan American Health Organization (PAHO)

Dr Galvão, a Brazilian national, received his medical degree in Brazil in 1977 and a Master’s Degree in Public Health with specialization in environmental epidemiology from the Escola Nacional de Saúde Pública Sérgio Arouca of Fundação Oswaldo Cruz (FIOCRUZ).  

Dr Galvão began his professional career in 1979 at the Instituto de Saúde da Bahia in Brazil.  Later, he became Coordinator of the Center for Studies on Workers' Health and Human Ecology (CESTEH) of FIOCRUZ.

Dr Galvão's professional career includes extensive teaching experience and a vast number of technical publications.  He was president of the Brazilian Society of Toxicology and is an active member of several professional associations.

Dr Galvão's career at PAHO started in 1991 as Environmental Epidemiologist of the Pan American Center for Human Ecology and Health (ECO). In 1994 he was appointed Regional Advisor on Environmental Quality and in July 2001 Coordinator of the Environmental Quality Program until February 2003.  In March 2003, he was appointed Area Manager of the Sustainable Development and Environmental Health Area. As of 1 July 2013, he was appointed Chief of the Special Program on Sustainable Development and Health Equity.

The Special Program on Sustainable Development and Health Equity deals with many relevant risks for public health in the Region of the Americas, such as: Violence, Workers’ Health, Environmental Health, Health Promotion, Climate Change, Local Development, Consumers' Health, Human Security, Social Determinants of Health, Toxicology, and Millennium Development Goals.

Dr Galvao is acting as PAHO Assistant Director since 29 July 2013.



Lorraine Johnson, JD, MBA
Co-Chair, Consumers United for Evidence-Based Healthcare (CUE) Steering Committee
Executive Director, LymeDisease.org

Lorraine Johnson, JD, MBA, is the Co-Chair of the steering committee of Consumers United for Evidence-Based Healthcare (CUE), a national coalition of approximately 40 consumer advocacy organizations. CUE was organized in 2003 when the US Cochrane Collaboration invited advocacy groups to join a consumer advocate-scientist partnership to improve the consumers’ ability to engage in and demand high quality healthcare. She serves as a consumer peer reviewer for The Cochrane Collaboration’s evidence-based protocols and reviews. She is also a member of the international Cochrane Consumer Network and presented to this group at the Cochrane Colloquium on the topic of “Evidence-Based Medicine: Evidence, Evidence Gaps and the Role of Stakeholders”.

She is the Chief Executive Officer of LymeDisease.org (LDo), a US national non-profit that publishes the only print journal dedicated to Lyme disease, maintains a national network of state-based internet groups, and funds research.  She has published over 40 publications in peer reviewed journals regarding medico-legal and ethical aspects of Lyme disease and evidence-based healthcare. She has spoken at universities, before state legislatures, the US Centers for Diseases Control, at the Canadian government consensus hearings on Lyme disease, before medical societies, at the IDSA guideline review hearing and at the Cochrane Collaboration (CCNET). She is a director and an officer of the International Lyme and Associated Diseases Society. She is also a member of the patient research grant reviewer panel for the U.S. Patient Centered Outcomes Research Institute.


Dr John N. Lavis, MD PhD
Director, McMaster Health Forum
Associate Director, Centre for Health Economics and Policy Analysis
Professor, Department of Clinical Epidemiology and Biostatistics and the Department of Political Science, McMaster University
Adjunct Professor of Global Health, Department of Global Health and Population, Harvard School of Public Health

John N. Lavis’ principal research interests include knowledge transfer and exchange in public policymaking environments and the politics of health systems. He led the creation and oversees the continuous updating of Health Systems Evidence (www.healthsystemsevidence.org), the world’s most comprehensive, free access point for high-quality evidence about how to strengthen or reform health systems, or how to get cost-effective programs, services and drugs to those who need them. He directs the Program in Policy Decision-Making (www.researchtopolicy.org) and oversees the Policy Liaison Office of the Canadian Cochrane Centre. He teaches an undergraduate course on the politics of health systems for the Bachelor of Health Sciences (Honours) program at McMaster University, a simulations course in the same program, and the doctoral seminar for the PhD in Health Policy program. He teaches a week-long module on ‘Using and supporting the use of research-based evidence in healthcare organizations and systems’ for Canada’s Executive Training for Research Application (EXTRA) program and runs one-day and two-day workshops on using research evidence for governments and international agencies. He is Co-Chair of the World Health Organization (WHO)-sponsored Evidence-Informed Policy Network (EVIPNet) Global Steering Group, President of the Pan American Health Organization (PAHO) Advisory Committee on Health Research, and a member of the WHO Advisory Committee on Health Research. John holds an MD from Queen's University, an MSc from the London School of Economics, and a PhD from Harvard University.



Dr France Légaré
, B.Sc. Arch MD, PhD, CCFP, FCFP
Canada Research Chair in Implementation of Shared Decision Making in Primary Care
Professor, Department of Family Medicine and Emergency Medicine, Université Laval
Researcher, Centre Hospitalier Universitaire de Québec (CHUQ)

Trained as an architect first, France is a family health practitioner in Quebec since 1990. She is full professor with the Department of Family Medicine and Emergency Medicine at Université Laval. Since June 1st 2006, she holds a Tier 2 Canada Research Chair in Implementation of Shared Decision Making in Primary Care. Since January 2012, she acts as Interim director, Research section at the department of family medicine and emergency medicine, Laval University. Since its founding in 2006 until December 2011, France was the scientific director of the ‘’Knowledge Transfer and Health Technology Assessment’’ research group at Centre Hospitalier Universitaire de Québec (CHUQ) Research Center. She has also been Representative to the Canadian Cochrane Regional Site of Université Laval since 1999. Her research program aims at providing healthcare professionals and patients with the needed tools to optimize decision-making in the context of primary care (shared decision making).



Chris Mavergames, MLIS
Head of Informatics and Knowledge Management, The Cochrane Collaboration

On September 1st, Chris was appointed Head of Informatics & Knowledge Management. Chris is charged with improving Cochrane’s information, technology and knowledge management functions, which will include the merging of the Web and IMS teams into a single department. From 2009 to September of this year, Chris lead Cochrane’s Web Team in the development and maintenance of Cochrane’s web presences; this includes more than 120 organizational, entity, and special project websites, as well as social media and other technology and knowledge management initiatives. He served as co-chair of the Cochrane Linked Data Project Board and has led Cochrane’s exploration into using linked data and semantic technologies to enhance the production and dissemination of Cochrane evidence since its inception in 2011.

Chris’ background is in information science and knowledge management with an MLIS degree from Long Island University in New York, USA. He has more than twelve years’ experience working with XML and related technologies, database management systems, web development technologies, metadata schema and controlled vocabularies and, most recently, linked data technologies. Chris began his career at CNN and Time Inc., in the relatively early days of digital and online publishing. He went on to become Director of Multimedia Resources at the New York City College of Technology, and then spent a year working on a digitisation project at the British Library, St. Pancras, London. Chris joined The Cochrane Collaboration in 2006 and took over leadership of the Web Team in 2009. In addition to his work with the Web Team, he is an author in the Cochrane Airways Group and a member of the Information Retrieval Methods Group.



Dr Andrew D. Oxman
, MD, MSc
Researcher, Global Health Unit, Norwegian Knowledge Center for the Health Services

Andy Oxman works as a health services researcher in the Global Health Unit at the Norwegian Knowledge Centre for the Health Services. His research over the past three decades has focused on ways of helping people to make informed choices about healthcare. His current research focuses primarily on supporting the use of research evidence to inform healthcare decisions in low and middle-income countries. Andy completed his medical training in the US in 1979. After that he worked as a general practitioner in northern Norway. He was at McMaster University in Canada from 1984 to 1994 before moving back to Norway. He was an editor of the Cochrane Reviewers’ Handbook from 1993 to 2003 and chair of the Cochrane Collaboration Steering Group from 1998 to 2000. He has been an editor for the Cochrane Effective Practice and Organization of Care Group since 1994.


Dr Jimmy Volmink,BSc, MBChB, DCH, MPH, DPhil
Dean, Faculty of Medicine and Health Sciences, Stellenbosch University
Director, South African Cochrane Centre

Jimmy Volmink is Dean of the Faculty of Medicine and Health Sciences, Stellenbosch University and Director of the South African Cochrane Centre, SA Medical Research Council. Previous appointments include GlaxoWellcome Chair of Primary Health Care, University of Cape Town and Director of Research and Analysis, Global Health Council, Washington DC. He is a member of committees and advisory boards of a large number of health and scientific organizations. In 2005 he was Guest Editor of the British Medical Journal Special Issue on Africa.  He has a special interest in the evaluation of interventions for chronic diseases, including TB, HIV and cardiovascular disease, and in translating evidence into policy and practice. 




Professor Thomas J Walley, MB, BCh, MD, FRCPI, FRCP, CBE
Director, NIHR Evaluation, Trials and Studies and Director of the HTA Programme
Professor, Health Services Research, Institute of Psychology, Health and Society, University of Liverpool

Qualified in medicine in Dublin in 1980.  He was appointed consultant physician in the Royal Liverpool University Hospital in 1991, and Professor of Clinical Pharmacology in Liverpool University in 1994.  He is a Fellow of the Royal Colleges of Physicians of London and of Ireland, and of the British Pharmacological Society.

Tom Walley has been Director of the HTA programme since January 2004. He also has responsibility for other NIHR programmes including the Health Service & Delivery Research programme, the Public Health Research programme, the Reviews Programme, and the MRC/NIHR funded Efficacy and Mechanisms Evaluations programme.

He formerly headed a research group at Liverpool University, focusing on drug prescribing, pharmaceutical policy, and clinical effectiveness and cost-effectiveness.

In June 2008, he was awarded a CBE by the Queen for his services to medicine.


Mark G. Wilson, M.A., DIP. JOUR., M.PHIL., M.M., FCMI
Chief Executive Officer, The Cochrane Collaboration

Mark started work as The Cochrane Collaboration’s new Chief Executive Officer in November 2012. He has extensive leadership experience at the highest levels in international humanitarian and development organizations, including the International Federation of Red Cross and Red Crescent Societies, where he was Chef de Cabinet, Senior Advisor to the Secretary General and the organisation’s Head of Planning. Previously he had been Head of Delegation in Mozambique; managed the Federation’s humanitarian operations in former Yugoslavia from 1996 to 2000; and in charge of the Federation’s Appeals & Reports for Africa and Europe from 1994 to 1996.

From 2004 to 2012 Mark was Executive Director of Panos London and Chair of the worldwide Panos Network of Institutes, which he helped to establish. Panos aims to ensure information and communication is effectively used to foster public debate, pluralism and democracy amongst poor and marginalized communities around the world.

Mark is a member of the Royal Institute of International Affairs and the International Institute for Strategic Studies, and a Fellow of the Chartered Management Institute in the UK. He holds Masters Degrees from universities in the UK and Canada in International Politics; Soviet and East European Studies; Journalism; and Management. As a former journalist in London and Hong Kong, and Communications Director of the Swiss-based Business Council for Sustainable Development, he is an experienced commentator on international economics, business and politics.



Please note: due to last minute scheduling conflicts, Professor Sir Michael G. Marmot is no longer able to present.